Direct-to-consumer-advertising of prescription medicines: A theoretical approach to understanding

Leadership in Health Services

Volumn 20, Issue 2, 2007, Pages 76-84

  Harker, Michael ^a   Harker, Debra ^a  

^a UNIVERSITY OF THE SUNSHINE COAST   (Australia)

Author keywords

Advertising; Medical prescriptions; Pharmaceuticals industry

Indexed keywords

DRUG;

ADVERTIZING; ARTICLE; CONSUMER; DRUG INDUSTRY; THEORETICAL MODEL;

ADVERTISING AS TOPIC; CONSUMER PARTICIPATION; DRUG INDUSTRY; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS;

EID: 77953899121     PISSN: 17511879     EISSN: None     Source Type: Journal    
DOI: 10.1108/17511870710745411     Document Type: Article

References (29)

1. Aikin, K.J., Swasey, J.L. and Braman, A.C. (2004), “Patients and physicians attitudes and behaviors associated with DTC promotion of prescription drugs – summary of FDA survey results”, FDA, November.
2. Arnold, M. (2005), “Changing channels”, Medical Marketing and Media, Vol. 40 No. 4.
3. Baukus, R. (2004), “DTC advertising”, Journal of Health Communication, Vol. 9 No. 6, pp. 563-4.
4. Berndt, E.R. (2005), “The United States' experience with direct-consumer advertising of prescription dugs: what have we learned”, paper presented at the International Conference on Pharmaceutical Innovation, Institute of Economics, Academia Sinica, Grand Hotel, Taipei, Taiwan, May 25-27, Session B4, “Consumerism and the Demand for Pharmaceuticals”.
5. Bowe, C. (2005), “Drug's patent win heartens Pfizer”, The Australian, 19 December, p. 30.
6. Calfee, J.E. (2002), “Public policy issues in the direct to consumer advertising of prescription drugs”, Journal of Public Policy and Marketing, Vol. 21 No. 2.
7. Chen Palmer and Partners (2000), Consistency of Restrictions on Medicine Advertising with the Bill of Rights Act, Memorandum to the Advertising Standards Authority, Wellington, 5 December.
8. Cohen, D., McCubbin, M., Collin, J. and Perodeu, G. (2001), “Medications as social phenomena”, Health, Vol. 5, pp. 441-69.
9. Deshpande, A.D., Menon, A., Perri, M. III and Zinkhan, G.M. (2004), “Direct to consumer advertising and its utility in healthcare decision making”, Journal of Healthcare Communication, Vol. 9, pp. 499-513.
10. Eagle, L. and Chamberlain, K. (2004), “Prescription medication advertising: professional discomfort and potential patient benefits – can the two be balanced?”, International Journal of Advertising, Vol. 23 No. 1, pp. 69-90.
11. Gilbody, S., Wilson, P. and Watt, I. (2005), “Benefits and harms of direct-to-consumer-advertising: a systematic review”, Quality and Safety in Healthcare, Vol. 14, pp. 246-50.
12. Hoek, J., Gendall, P. and Calfee, J. (2004), “Direct-to-consumer-advertising of prescription medicines in the United States and New Zealand: an analysis of regulatory approaches and consumer responses”, International Journal of Advertising, Vol. 23 No. 2, pp. 197-227.
13. Huh, J. and Becker, L.B. (2005), “Direct-to-consumer prescription drug advertising: understanding its consequences”, International Journal of Advertising, Vol. 24 No. 4, pp. 441-66.
14. Khan, K.S., Riet, G., Glanville, J., Sowden, A.J. and Kleijnen, J. (Eds) (2001), Undertaking Systematic Reviews of Research on Effectiveness. CRD's Guidance for those Carrying Out or Commissioning Reviews, NHS Centre for Reviews and Dissemination, University of York, York.
15. Kotler, P. and Keller, K.L. (2006), Marketing Management, Pearson Prentice Hall, Englewood Cliffs, NJ.
16. Kravitz, R.L., Epstein, R.M., Feldman, M.D., Franz, C.E., Azari, R., Wilkes, M.S., Hinton, L. and Franks, P. (2005), “Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial”, JAMA, 27 April, pp. 293-309.
17. Lavidge, R.J. and Steiner, G.A. (1961), “A model of predictive measurements of advertising effectiveness”, Journal of Marketing, Vol. 25 No. 6, pp. 59-62.
18. Lexchin, J. and Mintzes, B. (2002), “Direct-to-consumer-advertising of prescription drugs: the evidence says no”, Journal of Public Policy and Marketing, Vol. 21 No. 2.
19. Menon, A., Deshpande, A.D., Zinkhan, G.M. and Perri, M. III (2004), “A model assessing the effectiveness of direct-to-consumer-advertising”, International Journal of Advertising, Vol. 23 No. 1.
20. Mintzies, B., Barer, M.L., Kravitz, R.L., Bassett, K., Lexchin, J., Kanzanjian, A., Evans, R., Pan, R. and Marion, S.A. (2003), “How does direct-to-consumer-advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA”, Canadian Medical Association Journal, Vol. 169 No. 5, pp. 405-12.
21. Neutel, C.I. and Walop, W. (2005), “Drug utilization by men and women: why the difference?”, Drug Information Journal, Vol. 39 No. 3, pp. 299-311.
22. ORC International (2002), “Effectiveness of and attitudes toward medication advertising”, consultancy report prepared for NCL.
23. Pope, D. (1991), “Advertising as a consumer issue: an historical view”, Journal of Social Issues, Vol. 47 No. 1, pp. 41-56.
24. Presidents' Advisory Healthcare Quality Commission (1998), Quality First: Better Healthcare for all Americans, The Presidents' Advisory Commission on Consumer Protection, Bill of Rights and Responsibilities, available at: www.hcqualitycommission.gov/final/append a.html.
25. Prevention Magazine (2004), “Consumer reaction to DTC advertising of prescription medicines – 7th survey”, New York, NY.
26. Rosenthal, M.B., Berndt, E.R., Donohue, J.M., Frank, R.G. and Epstein, A.M. (2002), “Promotion of prescription drugs to consumers”, New England Journal of Medicine, Vol. 346 No. 7.
27. Vogt, D.U. (2005), “Direct-to-consumer-advertising of prescription drugs”, CRS Report for Congress, CRS Web.
28. Weissman, J.S., Blumenthal, D., Silk, A., Zapert, K., Newman, M. and Leitmann, R. (2003), “Consumers reports on the health effects of direct-to-consumer drug advertising”, Project Hope, 26 February, available at: www.healthaffairs.org (accessed 8 October 2006).
29. White, H.J., Draves, L.P., Soong, R. and Moore, C. (2004), “Ask your doctor! Measuring the effect of direct-to-consumer communications in the world's largest healthcare market”, International Journal of Advertising, Vol. 23 No. 1, pp. 53-68.